HomeCRDL • NASDAQ
Cardiol Therapeutics Inc
Follow
$1.08
1.89%
After Hours:(0.90%)+0.0097
$1.09
Closed: Oct 8, 7:55:14 PM GMT-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(CAD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.68M | -0.84% |
Net income | -8.35M | -26.76% |
Net profit margin | — | — |
Earnings per share | -0.10 | — |
EBITDA | -7.67M | 0.17% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(CAD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 18.20M | -24.25% |
Total assets | 19.94M | -24.23% |
Total liabilities | 8.13M | -25.76% |
Total equity | 11.81M | — |
Shares outstanding | 83.73M | — |
Price to book | 7.57 | — |
Return on assets | -84.55% | — |
Return on capital | -129.28% | — |
Cash Flow
Net Change in Cash
Net change in cash
(CAD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -8.35M | -26.76% |
Cash from operations | -4.55M | 4.71% |
Cash from investing | -6.44K | -69.45% |
Cash from financing | 20.42K | -73.85% |
Net change in cash | -5.10M | -11.99% |
Free cash flow | -1.57M | 45.66% |
Previous close
$1.06
Day range
$1.06 - $1.10
Year range
$0.77 - $2.24
Market cap
128.91M CAD
Avg Volume
773.17K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
About
CEO
Founded
2017
Headquarters
Website
Employees
18